sulmazole has been researched along with rolipram in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bristol, JA; Cain, MH; Weishaar, RE | 1 |
| Kelso, EJ; McDermott, BJ; Silke, B | 1 |
1 review(s) available for sulmazole and rolipram
| Article | Year |
|---|---|
A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; Calmodulin; Cardiotonic Agents; Guinea Pigs; Humans; Hypersensitivity; In Vitro Techniques; Lung Diseases; Myocardium; Platelet Aggregation; Substrate Specificity | 1985 |
1 other study(ies) available for sulmazole and rolipram
| Article | Year |
|---|---|
Actions of the novel vasodilator, flosequinan, in isolated ventricular cardiomyocytes.
Topics: Adenylyl Cyclases; Animals; Heart; Heart Atria; Heart Rate; Heart Ventricles; Imidazoles; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Papillary Muscles; Phosphodiesterase Inhibitors; Pyrrolidinones; Quinolines; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Rolipram; Stimulation, Chemical; Vasodilator Agents | 1995 |